Skip to main content

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.

Publisher: Bentham Science Publishers

Volume 8, Number 3, September 2008

Articles

Celiac Disease: Pathogenesis and Novel Therapeutic Strategies
pp. 152-158(7)
Authors: Baldassarre, Mariella; Laneve, Anna M.; Grosso, Roberto; Laforgia, Nicola

Favourites:
ADD

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease
pp. 159-172(14)
Authors: Cabral, G. A.; Griffin-Thomas, L.

Favourites:
ADD

Genome Study of Kidney Disease in the Age of Post Genome-Sequencing
pp. 173-183(11)
Authors: Doi, Kent; Okamoto, Koji; Tokunaga, Katsushi; Fujita, Toshiro; Noiri, Eisei

Favourites:
ADD

Harnessing CD36 to Rein in Inflammation
pp. 184-191(8)
Authors: Parsons, M. S.; Barrett, L.; Little, C.; Grant, M. D.

Favourites:
ADD

Trends in Metabolic Syndrome and Gene Networks in Human and Rodent Models
pp. 198-207(10)
Authors: Kraja, Aldi T.; Province, Michael A.; Huang, Pinchia; Jarvis, Joseph P.; Rice, Treva; Cheverud, James M.; Rao, D. C.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more